Colistin bladder instillation, an alternative way of treating multi-resistant Acinetobacter urinary tract infection: A case series and review of literature

Infection

Volumn 42, Issue 1, 2014, Pages 199-202

  Giua, R ^a   Pedone, C ^a   Cortese, L ^a   Antonelli Incalzi, R ^a,b  

^a Area di Geriatria   (Italy)

^b Incalzi Fondazione San Raffaele Cittadella Della Carità ^*  (Italy)

Author keywords

Acinetobacter; Bladder; Colistin; Infection; Instillation

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CEPHALOSPORIN; COLISTIN; CREATININE; STEROID;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ACUTE RESPIRATORY FAILURE; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL GROWTH; BACTERIUM COLONY; BACTERIUM CULTURE; BACTERIUM ISOLATION; BACTERIURIA; BLADDER CAPACITY; BLADDER DISCOMFORT; BLADDER IRRIGATION; CASE REPORT; CATHETER INFECTION; CATHETER REMOVAL; CHRONIC KIDNEY FAILURE; COLONY FORMING UNIT; CONGESTIVE HEART FAILURE; CREATININE BLOOD LEVEL; CYSTITIS; DIABETES MELLITUS; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; FEVER; HUMAN; INDWELLING URINARY CATHETER; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; MALE; MULTIDRUG RESISTANCE; PNEUMONIA; PYELONEPHRITIS; PYURIA; RESPIRATORY FUNCTION; SERRATIA MARCESCENS; STEROID THERAPY; TOPICAL TREATMENT; TREATMENT OUTCOME; URINALYSIS; URINARY TRACT INFECTION; URINE CULTURE; VESICOURETERAL REFLUX;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADMINISTRATION, INTRAVESICAL; AGED; ANTI-BACTERIAL AGENTS; COLISTIN; FEMALE; HUMANS; MALE; TREATMENT OUTCOME; URINARY TRACT INFECTIONS;

EID: 84898546553     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-013-0507-y     Document Type: Article

References (27)

1. Bayramoglu G, Kaya S, Besli Y, Cakir E, Can G, Akineden O, et al. Molecular epidemiology and the clinical significance of Acinetobacter baumannii complex isolated from cerebrospinal fluid in neurosurgical intensive care unit patients. Infection. 2012;40:163-72.
2. Cho YS, Yim H, Yang HT, Hur J, Chun W, Kim JH, et al. Use of parenteral colistin for the treatment of multiresistant Gram-negative organisms in major burn patients in South Korea. Infection. 2012;40:27-33.
3. Pitt TL, Sparrow M, Warner M, Stefanidou M. Survey of resistance of Pseudomonas aeruginosa from UK patients with cystic fibrosis to six commonly prescribed antimicrobial agents. Thorax. 2003;58:794-6. (Pubitemid 37094057)
4. Beringer P. The clinical use of colistin in patients with cystic fibrosis. Curr Opin Pulm Med. 2001;7:434-40. (Pubitemid 33065550)
5. Li J, Nation RL, Milne RW, Turnidge JD, Coulthard K. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. Int J Antimicrob Agents. 2005;25:11-25. (Pubitemid 40023341)
6. Bergan T, Fuglesang J. Polymyxin antibiotics: chemical and pharmacokinetic properties. Antibiot Chemother. 1982;31:119-44.
7. Davis SD, Iannetta A, Wedgwood RJ. Activity of colistin against Pseudomonas aeruginosa: inhibition by calcium. J Infect Dis. 1971;124:610-2.
8. Newton BA. The properties and mode of action of the polymyxins. Bacteriol Rev. 1956;20:14-27.
9. Schindler M, Osborn MJ. Interaction of divalent cations and polymyxin B with lipopolysaccharide. Biochemistry. 1979;18:4425-30. (Pubitemid 10247843)
10. Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis. 2005;40:1333-41. (Pubitemid 40570245)
11. Michalopoulos A, Kasiakou SK, Mastora Z, Rellos K, Kapaskelis AM, Falagas ME. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Crit Care. 2005;9:R53-9.
12. Kasiakou SK, Rafailidis PI, Liaropoulos K, Falagas ME. Cure of post-traumatic recurrent multiresistant Gram-negative rod meningitis with intraventricular colistin. J Infect. 2005;50:348-52. (Pubitemid 40533374)
13. Cunningham S, Prasad A, Collyer L, Carr S, Lynn IB, Wallis C. Bronchoconstriction following nebulised colistin in cystic fibrosis. Arch Dis Child. 2001;84:432-3. (Pubitemid 32411237)
14. Dodd ME, Abbott J, Maddison J, Moorcroft AJ, Webb AK. Effect of tonicity of nebulised colistin on chest tightness and pulmonary function in adults with cystic fibrosis. Thorax. 1997;52:656-8. (Pubitemid 27342218)
15. Van Nieuwkoop C, den Exter PL, Elzevier HW, den Hartigh J, van Dissel JT. Intravesical gentamicin for recurrent urinary tract infection in patients with intermittent bladder catheterisation. Int J Antimicrob Agents. 2010;36:485-90.
16. Pearman JW, Bailey M, Harper WE. Comparison of the efficacy of "Trisdine" and kanamycin-colistin bladder instillations in reducing bacteriuria during intermittent catheterisation of patients with acute spinal cord trauma. Br J Urol. 1988;62:140-4.
17. Waites KB, Canupp KC, Roper JF, Camp SM, Chen Y. Evaluation of 3 methods of bladder irrigation to treat bacteriuria in persons with neurogenic bladder. J Spinal Cord Med. 2006;29:217-26.
18. Linsenmeyer TA, Jain A, Thompson BW. Effectiveness of neomycin/polymyxin bladder irrigation to treat resistant urinary pathogens in those with spinal cord injury. J Spinal Cord Med. 1999;22:252-7.
19. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2007;51:3471-84. (Pubitemid 47519332)
20. Volkow-Fernandez P, Rodriguez CF, Cornejo-Juarez P. Intravesical colistin irrigation to treat multidrug-resistant Acinetobacter baumannii urinary tract infection: a case report. J Med Case Rep. 2012;6:426.
21. Li J, Turnidge J, Milne R, Nation RL, Coulthard K. In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrob Agents Chemother. 2001;45:781-5. (Pubitemid 32182025)
22. Schaeffer A, Schaeffer E. Infections of the urinary tract. Campbell-Walsh Urology. 9th ed. Philadelphia: Saunders Elsevier; 2007. p. 223-302.
23. Siroky MB. The aging bladder. Rev Urol. 2004;6:S3-7.
24. Gough M, Hancock RE, Kelly NM. Antiendotoxin activity of cationic peptide antimicrobial agents. Infect Immun. 1996;64:4922-7. (Pubitemid 26403942)
25. Ramakrishnan K, Scheid DC. Diagnosis and management of acute pyelonephritis in adults. Am Fam Physician. 2005;71:933-42. (Pubitemid 40321958)
26. Burns JL, Van Dalfsen JM, Shawar RM, Otto KL, Garber RL, Quan JM, et al. Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis. J Infect Dis. 1999;179:1190-6. (Pubitemid 29196500)
27. Littlewood JM, Koch C, Lambert PA, Høiby N, Elborn JS, Conway SP, et al. A ten year review of colomycin. Respir Med. 2000;94:632-40. (Pubitemid 30458785)